events & presentations
-
Intellia Therapeutics Company Overview
-
In Vivo Gene Knockout Followed by Targeted Gene Insertion Results in Simultaneous Reduced Mutant Protein Levels and Durable Transgene Expression” European Society of Cell and Gene Therapy 27th Annual Meeting October 25, 2019
-
“Engineering of Highly Functional and Specific Transgenic T Cell Receptor (TCR) T Cells Using CRISPR-Mediated In-Locus Insertion Combined with Endogenous TCR Knockout” European Society of Gene and Cell Therapy 27th Annual Meeting
-
“CRISPR/Cas9-Mediated Gene Knockout to Address Primary Hyperoxaluria” European Society of Gene and Cell Therapy 27th Annual Meeting
-
“In Silico, Biochemical and Cell-based Integrative Genomics Identifies Precise CRISPR / Cas9 Targets for Human Therapeutics” European Society of Gene and Cell Therapy 27th Annual Meeting
